# In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping

> **NCT07011212** · NA · NOT_YET_RECRUITING · sponsor: **Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud** · enrollment: 332 (estimated)

## Conditions studied

- Drug Allergy

## Interventions

- **DIAGNOSTIC_TEST:** BL-Predicter

## Key facts

- **NCT ID:** NCT07011212
- **Lead sponsor:** Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 332 (ESTIMATED)
- **Last updated:** 2025-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07011212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07011212, "In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07011212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*